Quantitative Diffusion-Weighted MRI Parameters and Human Papillomavirus Status in Oropharyngeal Squamous Cell Carcinoma

REFERENCES

1. 1.↵
   2. Ferlay J,
   3. Shin HR,
   4. Bray F, et al

   . Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893–917

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Leemans CR,
   3. Braakhuis BJ,
   4. Brakenhoff RH

   . The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9–22

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Fakhry C,
   3. Westra WH,
   4. Li S, et al

   . Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–69

   Abstract/FREE Full Text
4. 4.↵
   2. Ang KK,
   3. Harris J,
   4. Wheeler R, et al

   . Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010;363:24–35

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Braakhuis BJ,
   3. Snijders PJ,
   4. Keune WJ, et al

   . Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004;96:998–1006

   Abstract/FREE Full Text
6. 6.↵
   2. Smeets SJ,
   3. Brakenhoff RH,
   4. Ylstra B, et al

   . Genetic classification of oral and oropharyngeal carcinomas identifies subgroups with a different prognosis. Cell Oncol 2009;31:291–300

   PubMedWeb of Science
7. 7.↵
   2. Thariat J,
   3. Badoual C,
   4. Faure C, et al

   . Basaloid squamous cell carcinoma of the head and neck: role of HPV and implication in treatment and prognosis. J Clin Pathol 2010;63:857–66

   Abstract/FREE Full Text
8. 8.↵
   2. Chernock RD,
   3. El-Mofty SK,
   4. Thorstad WL, et al

   . HPV-related nonkeratinizing squamous cell carcinoma of the oropharynx: utility of microscopic features in predicting patient outcome. Head Neck Pathol 2009;3:186–94

   CrossRefPubMed
9. 9.↵
   2. Martincich L,
   3. Deantoni V,
   4. Bertotto I, et al

   . Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol 2012;22:1519–28

   CrossRefPubMed
10. 10.↵
    2. Choi SY,
    3. Chang YW,
    4. Park HJ, et al

    . Correlation of the apparent diffusion coefficiency values on diffusion-weighted imaging with prognostic factors for breast cancer. Br J Radiol 2012;85:e474–79

    Abstract/FREE Full Text
11. 11.↵
    2. Kim S,
    3. Loevner L,
    4. Quon H, et al

    . Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15:986–94

    Abstract/FREE Full Text
12. 12.↵
    2. Srinivasan A,
    3. Chenevert TL,
    4. Dwamena BA, et al

    . Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma. J Comput Assist Tomogr 2012;36:131–37

    CrossRefPubMed
13. 13.↵
    2. Chawla S,
    3. Kim S,
    4. Dougherty L, et al

    . Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. AJR Am J Roentgenol 2013;200:35–43

    CrossRefPubMed
14. 14.↵
    2. Hatakenaka M,
    3. Nakamura K,
    4. Yabuuchi H, et al

    . Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:339–45

    CrossRefPubMed
15. 15.↵
    2. Chernock RD,
    3. Lewis JS Jr.,
    4. Zhang Q, et al

    . Human papillomavirus-positive basaloid squamous cell carcinomas of the upper aerodigestive tract: a distinct clinicopathologic and molecular subtype of basaloid squamous cell carcinoma. Hum Pathol 2010;41:1016–23

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Nakahira M,
    3. Saito N,
    4. Yamaguchi H, et al

    . Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014;271:1219–25

    CrossRefPubMed
17. 17.↵
    2. Smeets SJ,
    3. Hesselink AT,
    4. Speel EJ, et al

    . A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007;121:2465–72

    CrossRefPubMedWeb of Science
18. 18.↵
    2. Rietbergen MM,
    3. Leemans CR,
    4. Bloemena E, et al

    . Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm. Int J Cancer 2013;132:1565–71

    CrossRefPubMedWeb of Science
19. 19.↵
    2. Lassen P,
    3. Eriksen JG,
    4. Hamilton-Dutoit S, et al

    . Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. J Clin Oncol 2009;27:1992–98

    Abstract/FREE Full Text
20. 20.↵
    2. Gillison ML,
    3. Koch WM,
    4. Capone RB, et al

    . Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:709–20

    Abstract/FREE Full Text
21. 21.↵
    2. El-Mofty SK,
    3. Patil S

    . Human papillomavirus (HPV)-related oropharyngeal nonkeratinizing squamous cell carcinoma: characterization of a distinct phenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:339–45

    CrossRefPubMedWeb of Science
22. 22.↵
    2. El-Mofty SK,
    3. Zhang MQ,
    4. Davila RM

    . Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol 2008;2:163–68

    CrossRefPubMed
23. 23.↵
    2. Mendelsohn AH,
    3. Lai CK,
    4. Shintaku IP, et al

    . Histopathologic findings of HPV and p16 positive HNSCC. Laryngoscope 2010;120:1788–94

    CrossRefPubMed
24. 24.↵
    2. Wang J,
    3. Takashima S,
    4. Takayama F, et al

    . Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001;220:621–30

    CrossRefPubMed
25. 25.↵
    2. Sumi M,
    3. Sakihama N,
    4. Sumi T, et al

    . Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. AJNR Am J Neuroradiol 2003;24:1627–34

    Abstract/FREE Full Text
26. 26.↵
    2. Kim S,
    3. Loevner LA,
    4. Quon H, et al

    . Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2010;31:262–68

    Abstract/FREE Full Text
27. 27.↵
    2. Tatum JL,
    3. Kelloff GJ,
    4. Gillies RJ, et al

    . Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. Int J Radiat Biol 2006;82:699–757

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Rietbergen MM,
    3. Snijders PJ,
    4. Beekzada D, et al

    . Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas. Int J Cancer 2014;134:2366–72

    CrossRefPubMed
29. 29.↵
    2. Vandecaveye V,
    3. Dirix P,
    4. De Keyzer F, et al

    . Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20:1703–14

    CrossRefPubMed
30. 30.↵
    2. King AD,
    3. Mo FK,
    4. Yu KH, et al

    . Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20:2213–20

    CrossRefPubMed